Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia
Authors:
Open Access
- 21 July 2016
- journal article
- review article
- Published by Springer Nature in Pneumonia
- Vol. 8 (1) , 1-10
Abstract
It is now well recognised that cardiac events occur relatively commonly in patients with acute community-acquired pneumonia. While these events are more frequent in patients with underlying risk factors—such as those with underlying chronic cardiovascular and respiratory comorbidities, the elderly, and in nursing home residents—they also occur in patients with no underlying risks other than severe pneumonia. Recent research elucidating the underlying pathogenic mechanisms related to these cardiac events has indicated a probable role for platelet activation, which is possibly exacerbated by pneumolysin in the case of pneumococcal infections. This, in turn, has resulted in the identification of possible therapeutic strategies targeting platelet activation, as well as the cardio-toxic activity of pneumolysin. These issues represent the primary focus of the current review.Keywords
This publication has 75 references indexed in Scilit:
- Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide AntibioticsMediators of Inflammation, 2012
- Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of HistonesPLOS ONE, 2012
- Association of prehospitalization aspirin therapy and acute lung injury: Results of a multicenter international observational study of at-risk patients*Critical Care Medicine, 2011
- Cardiac Complications in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational StudiesPLOS Medicine, 2011
- Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome*Critical Care Medicine, 2011
- Incidence of Cardiovascular Events After Hospital Admission for PneumoniaThe American Journal of Medicine, 2011
- Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemPharmaceuticals, 2010
- Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseJournal of Clinical Investigation, 2010
- Pneumococcal vaccination and risk of myocardial infarctionCanadian Medical Association Journal, 2008
- Influenza Vaccination as Secondary Prevention for Cardiovascular DiseaseCirculation, 2006